ArticleActa neurochirurgica2025
Timing of surgery for chronic subdural hematoma in patients with mild to moderate symptoms: a retrospective cohort study.
Article in Acta neurochirurgica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Time to surgery and postoperative functional outcomes among patients with chronic subdural haematomas.Journal of neurology, neurosurgery, and psychiatry · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBurr hole drainage is the mainstay of treatment for chronic subdural hematoma (cSDH). However, the impact of the interval between diagnosis and surgery on clinical outcome is unknown. This study investigates whether surgical timing affects outcome in patients with mild to moderate symptoms who do not require immediate surgery.
methodsWe performed a single center, retrospective cohort study of 330 surgically treated cSDH patients with a Markwalder Grading Scale score of 1-2, at the Amsterdam UMC, between 2012 and 2022. The interval between diagnosis and surgery was measured in hours and dichotomized (surgery within vs. after 24 h). To account for potential confounding by hematoma mass effect, patients were stratified based on midline shift (greater than 10 mm vs < 10 mm). Primary outcomes included reoperation rate, complication rate, 30-day mortality, length of hospital stay and discharge destination. Univariable and multivariable regression analyses were performed for each stratum.
resultsThe mean age of the cohort was 73 years, and 241 (73%) were male. The median time to surgery was 25 h (IQR 15-54). Among the 330 patients, 157 (48%) underwent surgery within 24 h after diagnosis. Patients who received early surgery (< 24 h) had a significantly higher proportion of midline shift > 10 mm compared to those undergoing later surgery (56% vs. 34%, p < 0.001). The use of anticoagulant or antiplatelet therapy did not differ between groups (47% vs 54%, p = 0.27). No significant association was found between surgical timing and any primary outcome across all strata.
conclusionIn patients with cSDH presenting with mild to moderately symptoms, the timing of surgery did not affect clinical outcome, particularly as delayed surgery did not result in poorer outcomes. These findings suggest that postponing surgery to daytime hours may be safe in this subgroup. Validation in prospective studies, ideally incorporating functional outcomes, is nevertheless required to confirm these results and guide clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.